Literature DB >> 16150250

Fetal response to maternal methadone administration.

Lauren M Jansson1, Janet Dipietro, Andrea Elko.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the effect of methadone on fetal neurobehavioral functions and maternal physiologic indicators. STUDY
DESIGN: Forty women attending a substance abuse treatment facility with otherwise uncomplicated pregnancies were evaluated at peak and trough methadone levels. Fetal measures included heart rate, variability, periodic accelerations/decelerations, motor activity, and fetal movement-heart rate coupling. Maternal measures included maternal heart period, variability, electrodermal skin conductance, respiration, and respiratory sinus arrhythmia (RSA). Repeated measure analysis of variance was used to evaluate within-subject changes.
RESULTS: At peak methadone, fetal heart rate was slower, less variable, and displayed fewer accelerations. Fetuses displayed less motor activity, and the integration between heart rate and motor activity was attenuated. Maternal heart rate and skin conductance were unchanged, but methadone administration was associated with lower respiratory rate and RSA, an indicator of parasympathetic tone.
CONCLUSION: Maternal methadone administration has significant effects on fetal behavioral functions that are independent of maternal effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16150250     DOI: 10.1016/j.ajog.2005.02.075

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  25 in total

1.  STUDIES IN FETAL BEHAVIOR: REVISITED, RENEWED, AND REIMAGINED.

Authors:  Janet A DiPietro; Kathleen A Costigan; Kristin M Voegtline
Journal:  Monogr Soc Res Child Dev       Date:  2015-09

Review 2.  Pharmacological Management of Opioid Use Disorder in Pregnant Women.

Authors:  Christine M Wilder; Theresa Winhusen
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

3.  Fetal heart rate and variability: stability and prediction to developmental outcomes in early childhood.

Authors:  Janet A DiPietro; Marc H Bornstein; Chun-Shin Hahn; Kathleen Costigan; Aristide Achy-Brou
Journal:  Child Dev       Date:  2007 Nov-Dec

Review 4.  Pregnancy and injecting drug use.

Authors:  James Bell; Lucy Harvey-Dodds
Journal:  BMJ       Date:  2008-06-07

Review 5.  Optimal Care for NAS: Are We Moving in the Wrong Direction?

Authors:  Lauren M Jansson; Martha L Velez
Journal:  Hosp Pediatr       Date:  2019-08

6.  Maternal buprenorphine treatment and fetal neurobehavioral development.

Authors:  Lauren M Jansson; Martha Velez; Krystle McConnell; Nancy Spencer; Michelle Tuten; Hendree E Jones; Van L King; Neeraj Gandotra; Lorraine A Milio; Kristin Voegtline; Janet A DiPietro
Journal:  Am J Obstet Gynecol       Date:  2017-02-07       Impact factor: 8.661

Review 7.  Beyond the Finnegan scoring system: Novel assessment and diagnostic techniques for the opioid-exposed infant.

Authors:  Davida M Schiff; Matthew R Grossman
Journal:  Semin Fetal Neonatal Med       Date:  2019-01-28       Impact factor: 3.926

8.  Prenatal methadone exposure and neonatal neurobehavioral functioning.

Authors:  Martha L Velez; Lauren M Jansson; Jennifer Schroeder; Erica Williams
Journal:  Pediatr Res       Date:  2009-12       Impact factor: 3.756

9.  Fetal heart rate and motor activity associations with maternal organochlorine levels: results of an exploratory study.

Authors:  Janet A DiPietro; Meghan F Davis; Kathleen A Costigan; Dana Boyd Barr
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-04-17       Impact factor: 5.563

10.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.